Kewaunee Scientific Corporation

NasdaqGM:KEQU Stock Report

Market Cap: US$110.0m

Kewaunee Scientific Balance Sheet Health

Financial Health criteria checks 5/6

Kewaunee Scientific has a total shareholder equity of $57.5M and total debt of $31.6M, which brings its debt-to-equity ratio to 54.9%. Its total assets and total liabilities are $132.0M and $74.5M respectively. Kewaunee Scientific's EBIT is $12.9M making its interest coverage ratio 7. It has cash and short-term investments of $24.2M.

Key information

54.9%

Debt to equity ratio

US$31.59m

Debt

Interest coverage ratio7x
CashUS$24.21m
EquityUS$57.51m
Total liabilitiesUS$74.51m
Total assetsUS$132.02m

Recent financial health updates

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17
Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10
With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23
Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11
Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19
Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

Financial Position Analysis

Short Term Liabilities: KEQU's short term assets ($92.7M) exceed its short term liabilities ($36.7M).

Long Term Liabilities: KEQU's short term assets ($92.7M) exceed its long term liabilities ($37.8M).


Debt to Equity History and Analysis

Debt Level: KEQU's net debt to equity ratio (12.8%) is considered satisfactory.

Reducing Debt: KEQU's debt to equity ratio has increased from 29.7% to 54.9% over the past 5 years.

Debt Coverage: KEQU's debt is well covered by operating cash flow (33.6%).

Interest Coverage: KEQU's interest payments on its debt are well covered by EBIT (7x coverage).


Balance Sheet


Discover healthy companies